Units Plummets After Novo Nordisk Deal Collapse
Shares of HIMS experienced a dramatic decline today following the unexpected withdrawal of its agreement with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending its stock price plummeting by more than 20%. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that it